Suven Pharmaceuticals Limited Market Cap ($4.40 Billion)

$4.40 Billion USD · Rs406.97 Billion INR · Rank #3768

Market Cap & Net Worth: Suven Pharmaceuticals Limited (SUVENPHAR)

Suven Pharmaceuticals Limited market cap. Suven Pharmaceuticals Limited (NSE:SUVENPHAR) has a market capitalization of $4.40 Billion (Rs406.97 Billion) as of November 5, 2026. Listed on the NSE stock exchange, this India-based company holds position #3768 globally and #168 in its home market, demonstrating a 0.00% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Suven Pharmaceuticals Limited's stock price Rs1063.80 by its total outstanding shares 382567008 (382.57 Million). Also see SUVENPHAR cash flow conversion for how efficiently the company converts equity into cash flow.

Suven Pharmaceuticals Limited Market Cap History (2020–2025)

Suven Pharmaceuticals Limited market cap history from 2020 to 2025. Data shows growth from $1.83 Billion to $4.40 Billion (41.59% CAGR). Check Suven Pharmaceuticals Limited (SUVENPHAR) share price today for real-time trading data and today's change.

Index Memberships

Suven Pharmaceuticals Limited is a constituent of 4 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY 500 NIFTY500	$3.02 Trillion	0.15%	#155 of 500
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.09 Trillion	0.41%	#83 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.10 Trillion	0.14%	#153 of 750
NIFTY SMALLCAP 250 NISM250	$388.02 Billion	1.13%	#12 of 250

Weight: Suven Pharmaceuticals Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Suven Pharmaceuticals Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Suven Pharmaceuticals Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Suven Pharmaceuticals Limited annual equity growth to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.37x

Suven Pharmaceuticals Limited's market cap is 0.37 times its annual revenue

Industry average: 0.58x Lower than industry average

Latest Price to Earnings (P/E) Ratio

1.66x

Suven Pharmaceuticals Limited's market cap is 1.66 times its annual earnings

Industry average: 13.51x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2020	$1.83 Billion	$8.07 Billion	$3.17 Billion	0.23x	0.58x
2021	$2.01 Billion	$9.80 Billion	$3.62 Billion	0.20x	0.55x
2022	$2.05 Billion	$12.90 Billion	$4.54 Billion	0.16x	0.45x
2023	$2.99 Billion	$13.40 Billion	$4.11 Billion	0.22x	0.73x
2024	$4.71 Billion	$10.51 Billion	$3.00 Billion	0.45x	1.57x
2025	$4.40 Billion	$11.98 Billion	$2.65 Billion	0.37x	1.66x

Competitor Companies of SUVENPHAR by Market Capitalization

Companies near Suven Pharmaceuticals Limited in the global market cap rankings as of November 5, 2026. Also see Suven Pharmaceuticals Limited total assets for a full breakdown of the balance sheet.

Key companies related to Suven Pharmaceuticals Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#509	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#534	GALDERMA GROUP AG	NYSE:GALDY	$50.42 Billion	$45.90
#580	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$46.03 Billion	CN¥49.31
#618	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€18.50

Market Capitalization of Suven Pharmaceuticals Limited (2020–2025)

Market capitalization of Suven Pharmaceuticals Limited from 2020 to today. Between 2020 and today, Suven Pharmaceuticals Limited's market cap moved from $1.83 Billion to $ 4.40 Billion, with a yearly change of 41.59%.

Year	Market Cap	Change (%)
2025	Rs4.40 Billion	-6.58%
2024	Rs4.71 Billion	+57.55%
2023	Rs2.99 Billion	+46.05%
2022	Rs2.05 Billion	+1.97%
2021	Rs2.01 Billion	+9.47%
2020	Rs1.83 Billion	--

End of Day Market Cap According to Different Sources

On Jul 15th, 2026 the market cap of Suven Pharmaceuticals Limited was reported to be:

Source	Market Cap
Yahoo Finance	$4.40 Billion USD
MoneyControl	$4.40 Billion USD
MarketWatch	$4.40 Billion USD
marketcap.company	$4.40 Billion USD
Reuters	$4.40 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Suven Pharmaceuticals Limited

NSE:SUVENPHAR India Drug Manufacturers - Specialty & Generic

Market Cap

$4.40 Billion

Rs406.97 Billion INR

Market Cap Rank

#3768 Global

#168 in India

Share Price

Rs1063.80

Change (1 day)

+0.00%

52-Week Range

Rs1063.80 - Rs1063.80

All Time High

Rs1334.20